Richat Abbas

Richat Abbas

UNVERIFIED PROFILE

Are you Richat Abbas?   Register this Author

Register author
Richat Abbas

Richat Abbas

Publications by authors named "Richat Abbas"

Are you Richat Abbas?   Register this Author

37Publications

748Reads

45Profile Views

A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects.

Clin Pharmacol Drug Dev 2019 Nov 27. Epub 2019 Nov 27.

Clinical Pharmacology, Pfizer Inc, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.749DOI Listing
November 2019

Population Pharmacokinetics of Desvenlafaxine: Pharmacokinetics in Korean Versus US Populations.

Clin Pharmacol Drug Dev 2018 05 11;7(4):441-450. Epub 2017 Dec 11.

Pfizer Inc, Collegeville, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpdd.419DOI Listing
May 2018

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder.

J Child Adolesc Psychopharmacol 2018 02 29;28(1):55-65. Epub 2017 Nov 29.

5 Department of Psychiatry and Behavioral Sciences, Johns Hopkins University and Kennedy Krieger Institute , Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cap.2017.0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771531PMC
February 2018

Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions.

Drug Metab Dispos 2017 04 6;45(4):390-398. Epub 2017 Feb 6.

Clinical Pharmacology, Pfizer Japan Inc., Tokyo, Japan (C.O.); Clinical Pharmacology, Pfizer Inc., San Diego, California (P.-H.H.); Clinical Pharmacology, Pfizer Essential Health, Collegeville, Pennsylvania (R.A.); and Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, San Diego, California (C.-M.L., S.Y.)

View Article

Download full-text PDF

Source
http://dmd.aspetjournals.org/lookup/doi/10.1124/dmd.116.0744
Publisher Site
http://dx.doi.org/10.1124/dmd.116.074450DOI Listing
April 2017

Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib.

Clin Pharmacokinet 2016 10;55(10):1191-1204

Pfizer Inc, San Diego, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40262-016-0391-6DOI Listing
October 2016

Population pharmacokinetic and pharmacodynamic analysis of bosutinib.

Drug Metab Pharmacokinet 2014 10;29(6):441-8. Epub 2014 Jun 10.

Pfizer Inc.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2133/dmpk.DMPK-13-RG-126DOI Listing
October 2015

Considerations in the early development of biosimilar products.

Drug Discov Today 2015 May 6;20 Suppl 2:1-9. Epub 2015 Jan 6.

Biotechnology Clinical Development, Pfizer, San Diego, CA 92121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drudis.2014.12.017DOI Listing
May 2015

Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors.

J Clin Oncol 2014 Jan 9;32(2):68-75. Epub 2013 Dec 9.

Leena Gandhi, Sara M. Tolaney, James M. Cleary, and Geoffrey I. Shapiro, Dana-Farber Cancer Institute; Eunice L. Kwak, Massachusetts General Hospital; Shuchi S. Pandya, Beth Israel Deaconess Medical Center, Boston; Anna Berkenblit and Mizue Krygowski, Aveo Pharmaceuticals; Revathi Ananthakrishnan and Kathleen W. Turnbull, Inventiv Health, Cambridge, MA; Rastislav Bahleda, Antoine Hollebecque, and Jean-Charles Soria, Insitut Gussav Roussy, Villejuif, France; Richat Abbas and Yali Liang, Pfizer, Collegeville, PA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2012.47.2787
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.47.2787DOI Listing
January 2014

A clinical study to examine the potential effect of lansoprazole on the pharmacokinetics of bosutinib when administered concomitantly to healthy subjects.

Clin Drug Investig 2013 Aug;33(8):589-95

Department of Clinical Pharmacology, Pfizer, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-013-0103-zDOI Listing
August 2013

Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects.

Cancer Chemother Pharmacol 2013 Jan 30;71(1):123-32. Epub 2012 Sep 30.

Department of Clinical Pharmacology, Pfizer Inc, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-012-1987-7
Publisher Site
http://dx.doi.org/10.1007/s00280-012-1987-7DOI Listing
January 2013

A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects.

Cancer Chemother Pharmacol 2012 Jan 21;69(1):221-7. Epub 2011 Jun 21.

Department of Clinical Pharmacology, Pfizer Inc, 500 Arcola Road, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1688-7DOI Listing
January 2012

Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy subjects.

J Clin Pharmacol 2011 Dec 8;51(12):1721-7. Epub 2010 Dec 8.

Pfizer Inc, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270010387427DOI Listing
December 2011

A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects.

Clin Cancer Res 2010 Aug 20;16(15):4016-23. Epub 2010 Jul 20.

Department of Clinical Pharmacology, Pfizer Inc., 500 Arcola Road, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-10-0280DOI Listing
August 2010

Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus.

Cancer Chemother Pharmacol 2009 Jul 18;64(2):263-70. Epub 2008 Nov 18.

Department of Early Development and Clinical Pharmacology, Wyeth Research, 500 Arcola Road, Collegeville, PA 19426, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-008-0865-9
Publisher Site
http://dx.doi.org/10.1007/s00280-008-0865-9DOI Listing
July 2009

Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.

J Clin Pharmacol 2004 Dec;44(12):1368-78

Department of Clinical Pharmacology, F. Hoffmann-La Roche Ltd, PDMP-Basel, Bldg. 15/1.036, CH-4070 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270004270147DOI Listing
December 2004

Development and validation of a sensitive liquid chromatographic-tandem mass spectrometric method for the determination of cromolyn sodium in human plasma.

J Chromatogr B Analyt Technol Biomed Life Sci 2003 May;788(1):159-66

Avantix Laboratories, Inc., 57 Read's Way, New Castle, DE 19720, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1570-0232(02)01041-3DOI Listing
May 2003